(2R,5R)-5-(6-amino-8-methylpurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol

• 分子结构分类: 有机化合物 - 核苷、核苷酸和类似物 - 嘌呤核苷
• 英文名称: (2R,5R)-5-(6-amino-8-methylpurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol
• 化学式: C₁₁H₁₅N₅O₃
• 分子量: 265.27
• InChiKey: IJRWMSFJUAOOAR-SPDVFEMOSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.1
• 重原子数：
  19
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.55
• 拓扑面积：
  119
• 氢给体数：
  3
• 氢受体数：
  7

文献信息

• Templated molecules and methods for using such molecules
  申请人：NUEVOLUTION A/S

  公开号：US10669538B2

  公开（公告）日：2020-06-02

  The present invention relates to a method for synthesising templated molecules. In one aspect of the invention, the templated molecules are linked to the template which templated the synthesis thereof. The invention allows the generation of libraries which can be screened for e.g. therapeutic activity.

  本发明涉及一种合成模板分子的方法。在本发明的一个方面，模板化分子与合成模板相连。本发明可生成可进行治疗等活性筛选的化合物库。
• TEMPLATED MOLECULES AND METHODS FOR USING SUCH MOLECULES
  申请人：NUEVOLUTION A/S

  公开号：US20170198283A1

  公开（公告）日：2017-07-13

  The present invention relates to a method for synthesising templated molecules. In one aspect of the invention, the templated molecules are linked to the template which templated the synthesis thereof. The invention allows the generation of libraries which can be screened for e.g. therapeutic activity.